These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 1185917
1. [Side effects of antituberculous drugs observed within six months after admission. Tuberculosis Research Committee, Ryoken (author's transl)]. Kekkaku; 1975 Jun; 50(6):161-7. PubMed ID: 1185917 [No Abstract] [Full Text] [Related]
2. [Side-effects of antituberculous drugs observed in five different regimens (author's transl)]. Aizawa H, Sakai K, Kishida K. Kekkaku; 1977 May; 52(5):229-34. PubMed ID: 886680 [No Abstract] [Full Text] [Related]
3. [Direct and late results of the treatment of severe cases of primary tuberculosis by Pronisone and antituberculous drugs (author's transl)]. Djurić-Milosavljević O, Moskovljević D. Plucne Bolesti Tuberk; 1979 May; 31(3-4):125-9. PubMed ID: 538114 [No Abstract] [Full Text] [Related]
5. [Adverse reactions of antituberculous agents, especially about its onset and duration]. Yamada H, Yasuoka A, Sasayama K, Doutsu Y, Hayashi T, Kohno S, Yamaguchi K, Hirota M, Hara K. Kekkaku; 1990 Sep 16; 65(9):563-8. PubMed ID: 2232434 [Abstract] [Full Text] [Related]
6. [A case of tuberculosis with a transient aggravation during initial phase of chemotherapy (author's transl)]. Kishimoto H, Kawachi H, Shimokata K. Kekkaku; 1982 Feb 15; 57(2):95-8. PubMed ID: 7069978 [No Abstract] [Full Text] [Related]
7. [Surveillance of adverse effects of antituberculous therapy upon the liver (author's transl)]. Estay S, Armas Merino R, Busel I, Baier E, Wolff C, Jabsa Z. Rev Med Chil; 1981 Mar 15; 109(3):212-20. PubMed ID: 7280406 [No Abstract] [Full Text] [Related]
8. [Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy]. Onaka A. Kekkaku; 1987 Dec 15; 62(12):672-5. PubMed ID: 3448353 [No Abstract] [Full Text] [Related]
9. [Clinical and laboratory studies in patients with pulmonary tuberculosis treated with pyrazinamide]. Savula MM, Smolenko MI, Romaniuk MD, Slivka IuI. Probl Tuberk; 1990 Dec 15; (11):25-8. PubMed ID: 2290809 [Abstract] [Full Text] [Related]
10. [Evaluation of the effectiveness of different combinations of antituberculosis drugs in the treatment of pulmonary TB (author's transl]. Zorić M, Jarebica M, Teofanović D, Toula Z, Milicević N. Plucne Bolesti Tuberk; 1977 Dec 15; 29(3-4):207-17. PubMed ID: 609627 [No Abstract] [Full Text] [Related]
11. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis]. Kobashi Y, Okimoto N, Matsushima T, Abe T, Nishimura K, Shishido S, Kawahara S, Shigeto E, Takeyama H, Kuraoka T. Kekkaku; 2000 Dec 15; 75(12):699-704. PubMed ID: 11201137 [Abstract] [Full Text] [Related]
12. [Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis]. Shmelev EI, Stepanian IE. Probl Tuberk; 1996 Dec 15; (6):57-60. PubMed ID: 9019774 [Abstract] [Full Text] [Related]
13. [Comparison of the therapeutic effects of secondary antituberculous drugs and evaluation of back-ground factors of the patients to the negative conversion of bacilli among the previously treated severe tuberculosis patients (author's transl)]. Yamamoto M, Sassa H, Suzuki T, Morishita M, Nagata A. Kekkaku; 1977 Aug 15; 52(8):399-404. PubMed ID: 410992 [No Abstract] [Full Text] [Related]
14. Glucose tolerance test during antituberculous drug therapy. Singh RP, Narang RK, Agarwal VB, Singh RK, Katiyar SK. Indian J Chest Dis Allied Sci; 1988 Aug 15; 30(3):183-8. PubMed ID: 3243600 [No Abstract] [Full Text] [Related]
15. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence]. Brändli O, Häcki MA, Scheel A, Stiefel M. Schweiz Med Wochenschr; 1983 Jan 22; 113(3):92-6. PubMed ID: 6828844 [Abstract] [Full Text] [Related]
16. [The influence of therapeutical and biological parameters on the appearance of side effects and complaints during intermittent chemotherapy of pulmonary tuberculosis (author's transl)]. Eule H, Iwainsky H. Prax Klin Pneumol; 1981 Aug 22; 35(8):347-53. PubMed ID: 7345430 [No Abstract] [Full Text] [Related]
17. [A survey on the duration of chemotherapy for pulmonary tuberculosis patients in Japan (author's transl)]. Kekkaku; 1978 Sep 22; 53(9):471-6. PubMed ID: 713226 [No Abstract] [Full Text] [Related]
18. [Studies on the prevention of side-effects by antituberculous drugs with special reference to effectiveness of pantethine (author's transl)]. Aoyagi T, Yamada Y, Kaneko K, Aizawa Y, Nanba A, Watabiki S, Kakazu Y, Hasegawa T, Fukuhara Y, Matumiya T, Komoriya T, Yoshida F, Kawamoto H, Ozawa R, Nishiyama K, Takahashi S, Nukada H, Kawame S, Fujita S, Oosato T, Murata A, Ishihara M, Kita R, Yoshitake H, Honda A, Hashimoto S, Kida E. Kekkaku; 1977 Nov 22; 52(11):563-8. PubMed ID: 599776 [No Abstract] [Full Text] [Related]
19. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan 22; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
20. Liver function tests in patients of pulmonary tuberculosis using four different drug regimens. Akbri MZ, Fatima N, ul Haque E, Shiekh AS, Bhatti MS. J Ayub Med Coll Abbottabad; 2001 Jan 22; 13(2):5-10. PubMed ID: 11732224 [Abstract] [Full Text] [Related] Page: [Next] [New Search]